相关实验视频
Updated: Jul 27, 2025
06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
201
急性严重性结肠炎的救生疗法:当前的实践和对未来的看法
Natalie Tamir-Degabli1, Nitsan Maharshak1, Nathaniel A Cohen1
1Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel; Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.
概括
在医院治疗急性严重性结肠炎 (ASUC) 需要快速做出决定,并采取多种治疗方法,以避免紧急切除肠道. 新兴疗法为ASUC患者提供了更好的结果和个性化医疗方法.
科学领域:
- 胃肠病学和肝病学 胃肠学和肝病学
- 内部医学 内部医学
- 临床药理学 临床药理学
背景情况:
- 患有急性严重性结肠炎 (ASUC) 的住院患者面临紧急肠切除的高风险.
- 包括诊断和治疗在内的ASUC最佳的医院内管理策略仍在讨论中.
- 类固醇耐药ASUC需要及时有效的救援或新型治疗干预措施.
研究的目的:
- 审查当前和新兴的治疗选择,用于住院患者的类固醇耐药性急性严重性结肠炎.
- 探索救援疗法,新生物,小分子和人工智能在优化ASUC治疗中的作用.
- 在ASUC中确定影响个性化药物的临床管理的患者因素.
主要方法:
- 对住院类固醇耐药ASUC的救援疗法 (氨酸抑制剂,因弗利西马布) 的研究进行系统审查.
- 审查新兴疗法,包括新生物制剂,小分子和抗生素.
- 对影响ASUC临床管理的患者因素的统计数据的分析.
主要成果:
- 近几十年来,几种新型药物和治疗方法在管理ASUC方面表现出了好处.
- 新的治疗方法提供了更好的疗效,安全性和方便性,提高了患者的生活质量.
- 根据患者个人资料 (疾病特征,实验室参数,偏好) 量身定制的个人化医疗是未来的方向.
结论:
- 随着ASUC治疗的不断变化,强调了多学科方法和多样化的治疗选择的重要性.
- 新疗法和个性化医疗策略旨在改善患者的治疗结果和生活质量.
- 未来的临床实践应该整合患者的特征,疾病参数,以及为量身定制的ASUC管理的偏好.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
179
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
179
01:21Inflammatory Bowel Disease V: Surgical Management
174
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
174
01:29Inflammatory Bowel Disease IV: Pharmacological Management
158
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
158
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
362
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
362
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
161
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
161
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
202
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
202